Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 16, 2005
J Am Soc Nephrol 16: 899-904, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004080689

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004080689v1
16/4/899    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagawa, T.
Right arrow Articles by Sautin, Y. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagawa, T.
Right arrow Articles by Sautin, Y. Y.

Cell Biology

Role of ERK1/2 and p38 Mitogen-Activated Protein Kinases in the Regulation of Thrombospondin-1 by TGF-{beta}1 in Rat Proximal Tubular Cells and Mouse Fibroblasts

Takahiko Nakagawa*, Hui Y. Lan{dagger}, Olena Glushakova*, Hong J. Zhu{dagger}, Duk-Hee Kang§, George F. Schreiner§, Erwin P. Böttinger, Richard J. Johnson* and Yuri Y. Sautin*

* Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, Florida; {dagger} Division of Nephrology-Medicine, Baylor College of Medicine, Houston, Texas; {ddagger} Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia; § Division of Nephrology, Ewha Women’s University Hospital, Seoul, Korea; || Scios Inc., Sunnyvale, California; and, Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York

Address correspondence to: Dr. Takahiko Nakagawa, Division of Nephrology, Hypertension and Transplantation, University of Florida, P.O. Box 100224, Gainesville, FL 32610-0224. Phone: 352-392-4008; Fax: 352-392-3581; E-mail:nakagt{at}medicine.ufl.edu

Received for publication August 19, 2004. Accepted for publication January 5, 2005.

Thrombospondin-1 (TSP-1) inhibits angiogenesis and activates latent TGF-{beta}1, both of which are strongly associated with progression of renal disease. Recently, it was reported that Smad2 but not Smad3 regulates TSP-1 expression in response to TGF-{beta}1 in rat tubular epithelial cells as well as in mouse fibroblasts. This study investigated the role of ERK1/2 and p38 mitogen-activated protein kinases (MAPK). TGF-{beta}1 activated both ERK1/2 and p38 in the rat proximal tubular cell line NRK52E. Blocking ERK1/2 and p38 inhibited TGF-{beta}1–induced TSP-1 mRNA and protein expression. Next, the cross-talk between Smad2 and ERK1/2 or p38 was examined. Whereas blocking of ERK1/2 or p38 failed to inhibit TGF-{beta}1–induced Smad2 activation, inhibition of Smad2 by Smad7 overexpression inhibited the phosphorylation of ERK1/2 but not p38 in response to TGF-{beta}1. Similar results were observed using mouse fibroblasts from Smad2 knockout embryos, in that TGF-{beta}1 was able to activate p38 but not ERK1/2 in this cell line. In conclusion, TSP-1 expression is regulated by both ERK1/2 and p38 MAPK in rat proximal tubular cells and mouse fibroblasts in response to TGF-{beta}1. The ERK1/2 activation is dependent on Smad2 activation, whereas the p38 activation occurs independent of Smad2. Because TSP-1 is a major antiangiogenic molecule and an activator of TGF-{beta}1, this provides an important insight to the mechanism by which TGF-{beta}1 may mediate interstitial fibrosis and progressive renal disease.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Giehl, A. Graness, and M. Goppelt-Struebe
The small GTPase Rac-1 is a regulator of mesangial cell morphology and thrombospondin-1 expression
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F407 - F413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Belmadani, J. Bernal, C.-C. Wei, M. A. Pallero, L. Dell'Italia, J. E. Murphy-Ullrich, and K. H. Berecek
A Thrombospondin-1 Antagonist of Transforming Growth Factor-{beta} Activation Blocks Cardiomyopathy in Rats with Diabetes and Elevated Angiotensin II
Am. J. Pathol., September 1, 2007; 171(3): 777 - 789.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Tran and J. T. Neary
Purinergic signaling induces thrombospondin-1 expression in astrocytes
PNAS, June 13, 2006; 103(24): 9321 - 9326.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Yung, C. Y. Y. Lee, Q. Zhang, S. K. Lau, R. C. W. Tsang, and T. M. Chan
Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-{beta}1 dependent and TGF-{beta}1 independent pathways
Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1504 - 1513.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP